Conference abstract · 28 Sep 2015
Conference abstractPublished 28 Sep 2015
Apitherapy in immune mediated disorders
National Research Center, Egypt
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Apitherapy, or âÂ?Â?bee therapyâÂ? (from the Latin apis which means bee) is the medicinal use of products made by honey bees. Products of the honey bee include bee venom, honey, pollen, royal jelly, propolis and beeswax. The exact origin of Apitherapy is difficult to pinpoint and can be traced back, in a general sense, to ancient Egypt, Greece and China. Use of honey and other bee products can be traced back thousands of years and healing properties are included in many religious texts including the Veda, Bible, and Quran. These are mostly attributed to nutritional benefits of consumption of bee-products and not use of bee venom. Honey bee venom contains at least 18 active substances. Melittin, the most prevalent substance, is one of the most potent anti-inflammatory agents. Adolapin is another strong anti-inflammatory substance and inhibits cyclo-oxygenase; it thus has analgesic activity as well. Apamin inhibits complement C3 activity and blocks calcium-dependent potassium channels, thus enhancing nerve transmission. Other substances, such as Compound X, hyaluronidase, phospholipase A2, histamine and Mast Cell Degranulating Protein (MSDP), are involved in the inflammatory response of venom. Thus the trial of Apitherapy in a range of immune mediated disorders such as IBD is a promising field to control such chronic gastrointestinal disorders that need long-term and medications with multiple side effects and as a trial to keep the patients in a remission state to control their life disabling symptoms and signs.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 22 Mar 2024
Apitherapy and Immune Support: Enhancing Wellness with Bee Products
Article · 24 Dec 2025
Hypersensitivity Reactions and Their Role in Immune Mediated Disorders
Mini review · 29 Mar 2024
Unraveling the Therapeutic Potential of Anti cytokine Antibodies in Immune-Mediated Disorders
Commentary · 1 Feb 2023
Multiple Sclerosis (MS): Most Prevalent Immune-Mediated Disorder
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Perspective · 10 Sep 2026
Cellular Pathways Involved in Mucosal Immunity and Protection Against Environmental Challenges
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Ehab Kamal”

